Industry Research Reports
Home > Reports > Medical Devices & Consumables > Global Antithrombogenic Heparin Coating Market Research Report 2024
Global Antithrombogenic Heparin Coating Market Research Report 2024
Industry: Medical Devices & Consumables
Published Date: 2024-12-15
Pages: 86 Pages
Report ld: 3404308
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Antithrombogenic Heparin Coating Market Size(US$)
CAGR 2024-2030
9.2%
Market Size,2030
USD 261
Million
Market Snapshot
Market Size in 2024 (Value)
US$ 154 million
Market Forecast in 2030(Value)
US$ 261 million
CAGR
9.2%
Years Considered
2019-2030
Base Year
2024
Forecast Period
2024-2030
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Antithrombogenic Heparin Coating was valued at US$ 142 million in the year 2023 and is projected to reach a revised size of US$ 261 million by 2030, growing at a CAGR of 9.2% during the forecast period.
Antithrombogenic heparin coating refers to a layer of heparin that is applied to the surface of medical devices. Heparin is a glycosaminoglycan with a high negative charge density. It is a natural anticoagulant substance that can prevent blood from clotting. The heparin used in coatings usually has a certain purity and molecular weight range to ensure its anticoagulant effect.
North American market for Antithrombogenic Heparin Coating is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Antithrombogenic Heparin Coating is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Antithrombogenic Heparin Coating include Carmeda AB (Gore), Biointeractions, Medtronic, Surmodics, Corline, Toyobo, jMedtech, Biosurf, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Antithrombogenic Heparin Coating, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antithrombogenic Heparin Coating.
The Antithrombogenic Heparin Coating market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Antithrombogenic Heparin Coating market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antithrombogenic Heparin Coating manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
MARKET SEGMENTATION
By Company
- Carmeda AB (Gore)
- Biointeractions
- Medtronic
- Surmodics
- Corline
- Toyobo
- jMedtech
- Biosurf
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Covalently Bonded Coatings
- Physisorption Coatings
Segment by Application
- Catheters
- Stents
- Implants
- Others
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Antithrombogenic Heparin Coating manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Antithrombogenic Heparin Coating in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Antithrombogenic Heparin Coating Market Overview
1.1 Product Definition
1.2 Antithrombogenic Heparin Coating by Type
1.2.1 Global Antithrombogenic Heparin Coating Market Value Comparison by Type (2024-2030)
1.2.2 Covalently Bonded Coatings
1.2.3 Physisorption Coatings
1.3 Antithrombogenic Heparin Coating by Application
1.3.1 Global Antithrombogenic Heparin Coating Market Value by Application (2024-2030)
1.3.2 Catheters
1.3.3 Stents
1.3.4 Implants
1.3.5 Others
1.4 Global Antithrombogenic Heparin Coating Market Size Estimates and Forecasts
1.4.1 Global Antithrombogenic Heparin Coating Revenue 2019-2030
1.4.2 Global Antithrombogenic Heparin Coating Sales 2019-2030
1.4.3 Global Antithrombogenic Heparin Coating Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Antithrombogenic Heparin Coating Market Competition by Manufacturers
2.1 Global Antithrombogenic Heparin Coating Sales Market Share by Manufacturers (2019-2024)
2.2 Global Antithrombogenic Heparin Coating Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Antithrombogenic Heparin Coating Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Antithrombogenic Heparin Coating, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Antithrombogenic Heparin Coating, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Antithrombogenic Heparin Coating, Product Type & Application
2.7 Global Key Manufacturers of Antithrombogenic Heparin Coating, Date of Enter into This Industry
2.8 Global Antithrombogenic Heparin Coating Market Competitive Situation and Trends
2.8.1 Global Antithrombogenic Heparin Coating Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Antithrombogenic Heparin Coating Players Market Share by Revenue
2.8.3 Global Antithrombogenic Heparin Coating Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Antithrombogenic Heparin Coating Market Scenario by Region
3.1 Global Antithrombogenic Heparin Coating Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Antithrombogenic Heparin Coating Sales by Region: 2019-2030
3.2.1 Global Antithrombogenic Heparin Coating Sales by Region: 2019-2024
3.2.2 Global Antithrombogenic Heparin Coating Sales by Region: 2025-2030
3.3 Global Antithrombogenic Heparin Coating Revenue by Region: 2019-2030
3.3.1 Global Antithrombogenic Heparin Coating Revenue by Region: 2019-2024
3.3.2 Global Antithrombogenic Heparin Coating Revenue by Region: 2025-2030
3.4 North America Antithrombogenic Heparin Coating Market Facts & Figures by Country
3.4.1 North America Antithrombogenic Heparin Coating Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Antithrombogenic Heparin Coating Sales by Country (2019-2030)
3.4.3 North America Antithrombogenic Heparin Coating Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Antithrombogenic Heparin Coating Market Facts & Figures by Country
3.5.1 Europe Antithrombogenic Heparin Coating Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Antithrombogenic Heparin Coating Sales by Country (2019-2030)
3.5.3 Europe Antithrombogenic Heparin Coating Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Antithrombogenic Heparin Coating Market Facts & Figures by Region
3.6.1 Asia Pacific Antithrombogenic Heparin Coating Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Antithrombogenic Heparin Coating Sales by Region (2019-2030)
3.6.3 Asia Pacific Antithrombogenic Heparin Coating Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Antithrombogenic Heparin Coating Market Facts & Figures by Country
3.7.1 Latin America Antithrombogenic Heparin Coating Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Antithrombogenic Heparin Coating Sales by Country (2019-2030)
3.7.3 Latin America Antithrombogenic Heparin Coating Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Antithrombogenic Heparin Coating Market Facts & Figures by Country
3.8.1 Middle East and Africa Antithrombogenic Heparin Coating Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Antithrombogenic Heparin Coating Sales by Country (2019-2030)
3.8.3 Middle East and Africa Antithrombogenic Heparin Coating Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Antithrombogenic Heparin Coating Sales by Type (2019-2030)
4.1.1 Global Antithrombogenic Heparin Coating Sales by Type (2019-2024)
4.1.2 Global Antithrombogenic Heparin Coating Sales by Type (2025-2030)
4.1.3 Global Antithrombogenic Heparin Coating Sales Market Share by Type (2019-2030)
4.2 Global Antithrombogenic Heparin Coating Revenue by Type (2019-2030)
4.2.1 Global Antithrombogenic Heparin Coating Revenue by Type (2019-2024)
4.2.2 Global Antithrombogenic Heparin Coating Revenue by Type (2025-2030)
4.2.3 Global Antithrombogenic Heparin Coating Revenue Market Share by Type (2019-2030)
4.3 Global Antithrombogenic Heparin Coating Price by Type (2019-2030)
5 Segment by Application
5.1 Global Antithrombogenic Heparin Coating Sales by Application (2019-2030)
5.1.1 Global Antithrombogenic Heparin Coating Sales by Application (2019-2024)
5.1.2 Global Antithrombogenic Heparin Coating Sales by Application (2025-2030)
5.1.3 Global Antithrombogenic Heparin Coating Sales Market Share by Application (2019-2030)
5.2 Global Antithrombogenic Heparin Coating Revenue by Application (2019-2030)
5.2.1 Global Antithrombogenic Heparin Coating Revenue by Application (2019-2024)
5.2.2 Global Antithrombogenic Heparin Coating Revenue by Application (2025-2030)
5.2.3 Global Antithrombogenic Heparin Coating Revenue Market Share by Application (2019-2030)
5.3 Global Antithrombogenic Heparin Coating Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Carmeda AB (Gore)
6.1.1 Carmeda AB (Gore) Company Information
6.1.2 Carmeda AB (Gore) Description and Business Overview
6.1.3 Carmeda AB (Gore) Antithrombogenic Heparin Coating Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Carmeda AB (Gore) Antithrombogenic Heparin Coating Product Portfolio
6.1.5 Carmeda AB (Gore) Recent Developments/Updates
6.2 Biointeractions
6.2.1 Biointeractions Company Information
6.2.2 Biointeractions Description and Business Overview
6.2.3 Biointeractions Antithrombogenic Heparin Coating Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Biointeractions Antithrombogenic Heparin Coating Product Portfolio
6.2.5 Biointeractions Recent Developments/Updates
6.3 Medtronic
6.3.1 Medtronic Company Information
6.3.2 Medtronic Description and Business Overview
6.3.3 Medtronic Antithrombogenic Heparin Coating Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Medtronic Antithrombogenic Heparin Coating Product Portfolio
6.3.5 Medtronic Recent Developments/Updates
6.4 Surmodics
6.4.1 Surmodics Company Information
6.4.2 Surmodics Description and Business Overview
6.4.3 Surmodics Antithrombogenic Heparin Coating Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Surmodics Antithrombogenic Heparin Coating Product Portfolio
6.4.5 Surmodics Recent Developments/Updates
6.5 Corline
6.5.1 Corline Company Information
6.5.2 Corline Description and Business Overview
6.5.3 Corline Antithrombogenic Heparin Coating Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Corline Antithrombogenic Heparin Coating Product Portfolio
6.5.5 Corline Recent Developments/Updates
6.6 Toyobo
6.6.1 Toyobo Company Information
6.6.2 Toyobo Description and Business Overview
6.6.3 Toyobo Antithrombogenic Heparin Coating Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Toyobo Antithrombogenic Heparin Coating Product Portfolio
6.6.5 Toyobo Recent Developments/Updates
6.7 jMedtech
6.7.1 jMedtech Company Information
6.7.2 jMedtech Description and Business Overview
6.7.3 jMedtech Antithrombogenic Heparin Coating Sales, Revenue and Gross Margin (2019-2024)
6.7.4 jMedtech Antithrombogenic Heparin Coating Product Portfolio
6.7.5 jMedtech Recent Developments/Updates
6.8 Biosurf
6.8.1 Biosurf Company Information
6.8.2 Biosurf Description and Business Overview
6.8.3 Biosurf Antithrombogenic Heparin Coating Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Biosurf Antithrombogenic Heparin Coating Product Portfolio
6.8.5 Biosurf Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Antithrombogenic Heparin Coating Industry Chain Analysis
7.2 Antithrombogenic Heparin Coating Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Antithrombogenic Heparin Coating Production Mode & Process
7.4 Antithrombogenic Heparin Coating Sales and Marketing
7.4.1 Antithrombogenic Heparin Coating Sales Channels
7.4.2 Antithrombogenic Heparin Coating Distributors
7.5 Antithrombogenic Heparin Coating Customers
8 Antithrombogenic Heparin Coating Market Dynamics
8.1 Antithrombogenic Heparin Coating Industry Trends
8.2 Antithrombogenic Heparin Coating Market Drivers
8.3 Antithrombogenic Heparin Coating Market Challenges
8.4 Antithrombogenic Heparin Coating Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Antithrombogenic Heparin Coating Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Antithrombogenic Heparin Coating Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Antithrombogenic Heparin Coating Market Competitive Situation by Manufacturers in 2023
Table 4. Global Antithrombogenic Heparin Coating Sales (Tons) of Key Manufacturers (2019-2024)
Table 5. Global Antithrombogenic Heparin Coating Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Antithrombogenic Heparin Coating Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Antithrombogenic Heparin Coating Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Antithrombogenic Heparin Coating Average Price (US$/Kg) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Antithrombogenic Heparin Coating, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Antithrombogenic Heparin Coating, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Antithrombogenic Heparin Coating, Product Type & Application
Table 12. Global Key Manufacturers of Antithrombogenic Heparin Coating, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Antithrombogenic Heparin Coating by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antithrombogenic Heparin Coating as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Antithrombogenic Heparin Coating Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Antithrombogenic Heparin Coating Sales by Region (2019-2024) & (Tons)
Table 18. Global Antithrombogenic Heparin Coating Sales Market Share by Region (2019-2024)
Table 19. Global Antithrombogenic Heparin Coating Sales by Region (2025-2030) & (Tons)
Table 20. Global Antithrombogenic Heparin Coating Sales Market Share by Region (2025-2030)
Table 21. Global Antithrombogenic Heparin Coating Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Antithrombogenic Heparin Coating Revenue Market Share by Region (2019-2024)
Table 23. Global Antithrombogenic Heparin Coating Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Antithrombogenic Heparin Coating Revenue Market Share by Region (2025-2030)
Table 25. North America Antithrombogenic Heparin Coating Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Antithrombogenic Heparin Coating Sales by Country (2019-2024) & (Tons)
Table 27. North America Antithrombogenic Heparin Coating Sales by Country (2025-2030) & (Tons)
Table 28. North America Antithrombogenic Heparin Coating Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Antithrombogenic Heparin Coating Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Antithrombogenic Heparin Coating Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Antithrombogenic Heparin Coating Sales by Country (2019-2024) & (Tons)
Table 32. Europe Antithrombogenic Heparin Coating Sales by Country (2025-2030) & (Tons)
Table 33. Europe Antithrombogenic Heparin Coating Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Antithrombogenic Heparin Coating Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Antithrombogenic Heparin Coating Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Antithrombogenic Heparin Coating Sales by Region (2019-2024) & (Tons)
Table 37. Asia Pacific Antithrombogenic Heparin Coating Sales by Region (2025-2030) & (Tons)
Table 38. Asia Pacific Antithrombogenic Heparin Coating Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Antithrombogenic Heparin Coating Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Antithrombogenic Heparin Coating Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Antithrombogenic Heparin Coating Sales by Country (2019-2024) & (Tons)
Table 42. Latin America Antithrombogenic Heparin Coating Sales by Country (2025-2030) & (Tons)
Table 43. Latin America Antithrombogenic Heparin Coating Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Antithrombogenic Heparin Coating Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Antithrombogenic Heparin Coating Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Antithrombogenic Heparin Coating Sales by Country (2019-2024) & (Tons)
Table 47. Middle East and Africa Antithrombogenic Heparin Coating Sales by Country (2025-2030) & (Tons)
Table 48. Middle East and Africa Antithrombogenic Heparin Coating Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Antithrombogenic Heparin Coating Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Antithrombogenic Heparin Coating Sales (Tons) by Type (2019-2024)
Table 51. Global Antithrombogenic Heparin Coating Sales (Tons) by Type (2025-2030)
Table 52. Global Antithrombogenic Heparin Coating Sales Market Share by Type (2019-2024)
Table 53. Global Antithrombogenic Heparin Coating Sales Market Share by Type (2025-2030)
Table 54. Global Antithrombogenic Heparin Coating Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Antithrombogenic Heparin Coating Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Antithrombogenic Heparin Coating Revenue Market Share by Type (2019-2024)
Table 57. Global Antithrombogenic Heparin Coating Revenue Market Share by Type (2025-2030)
Table 58. Global Antithrombogenic Heparin Coating Price (US$/Kg) by Type (2019-2024)
Table 59. Global Antithrombogenic Heparin Coating Price (US$/Kg) by Type (2025-2030)
Table 60. Global Antithrombogenic Heparin Coating Sales (Tons) by Application (2019-2024)
Table 61. Global Antithrombogenic Heparin Coating Sales (Tons) by Application (2025-2030)
Table 62. Global Antithrombogenic Heparin Coating Sales Market Share by Application (2019-2024)
Table 63. Global Antithrombogenic Heparin Coating Sales Market Share by Application (2025-2030)
Table 64. Global Antithrombogenic Heparin Coating Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Antithrombogenic Heparin Coating Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Antithrombogenic Heparin Coating Revenue Market Share by Application (2019-2024)
Table 67. Global Antithrombogenic Heparin Coating Revenue Market Share by Application (2025-2030)
Table 68. Global Antithrombogenic Heparin Coating Price (US$/Kg) by Application (2019-2024)
Table 69. Global Antithrombogenic Heparin Coating Price (US$/Kg) by Application (2025-2030)
Table 70. Carmeda AB (Gore) Company Information
Table 71. Carmeda AB (Gore) Description and Business Overview
Table 72. Carmeda AB (Gore) Antithrombogenic Heparin Coating Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 73. Carmeda AB (Gore) Antithrombogenic Heparin Coating Product
Table 74. Carmeda AB (Gore) Recent Developments/Updates
Table 75. Biointeractions Company Information
Table 76. Biointeractions Description and Business Overview
Table 77. Biointeractions Antithrombogenic Heparin Coating Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 78. Biointeractions Antithrombogenic Heparin Coating Product
Table 79. Biointeractions Recent Developments/Updates
Table 80. Medtronic Company Information
Table 81. Medtronic Description and Business Overview
Table 82. Medtronic Antithrombogenic Heparin Coating Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 83. Medtronic Antithrombogenic Heparin Coating Product
Table 84. Medtronic Recent Developments/Updates
Table 85. Surmodics Company Information
Table 86. Surmodics Description and Business Overview
Table 87. Surmodics Antithrombogenic Heparin Coating Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 88. Surmodics Antithrombogenic Heparin Coating Product
Table 89. Surmodics Recent Developments/Updates
Table 90. Corline Company Information
Table 91. Corline Description and Business Overview
Table 92. Corline Antithrombogenic Heparin Coating Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 93. Corline Antithrombogenic Heparin Coating Product
Table 94. Corline Recent Developments/Updates
Table 95. Toyobo Company Information
Table 96. Toyobo Description and Business Overview
Table 97. Toyobo Antithrombogenic Heparin Coating Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 98. Toyobo Antithrombogenic Heparin Coating Product
Table 99. Toyobo Recent Developments/Updates
Table 100. jMedtech Company Information
Table 101. jMedtech Description and Business Overview
Table 102. jMedtech Antithrombogenic Heparin Coating Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 103. jMedtech Antithrombogenic Heparin Coating Product
Table 104. jMedtech Recent Developments/Updates
Table 105. Biosurf Company Information
Table 106. Biosurf Description and Business Overview
Table 107. Biosurf Antithrombogenic Heparin Coating Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 108. Biosurf Antithrombogenic Heparin Coating Product
Table 109. Biosurf Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Antithrombogenic Heparin Coating Distributors List
Table 113. Antithrombogenic Heparin Coating Customers List
Table 114. Antithrombogenic Heparin Coating Market Trends
Table 115. Antithrombogenic Heparin Coating Market Drivers
Table 116. Antithrombogenic Heparin Coating Market Challenges
Table 117. Antithrombogenic Heparin Coating Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
Table 121. Authors List of This Report
List of Figures
Figure 1. Product Picture of Antithrombogenic Heparin Coating
Figure 2. Global Antithrombogenic Heparin Coating Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Antithrombogenic Heparin Coating Market Share by Type: 2023 & 2030
Figure 4. Covalently Bonded Coatings Product Picture
Figure 5. Physisorption Coatings Product Picture
Figure 6. Global Antithrombogenic Heparin Coating Market Value by Application (2024-2030) & (US$ Million)
Figure 7. Global Antithrombogenic Heparin Coating Market Share by Application: 2023 & 2030
Figure 8. Catheters
Figure 9. Stents
Figure 10. Implants
Figure 11. Others
Figure 12. Global Antithrombogenic Heparin Coating Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Antithrombogenic Heparin Coating Market Size (2019-2030) & (US$ Million)
Figure 14. Global Antithrombogenic Heparin Coating Sales (2019-2030) & (Tons)
Figure 15. Global Antithrombogenic Heparin Coating Average Price (US$/Kg) & (2019-2030)
Figure 16. Antithrombogenic Heparin Coating Report Years Considered
Figure 17. Antithrombogenic Heparin Coating Sales Share by Manufacturers in 2023
Figure 18. Global Antithrombogenic Heparin Coating Revenue Share by Manufacturers in 2023
Figure 19. Global 5 and 10 Largest Antithrombogenic Heparin Coating Players: Market Share by Revenue in Antithrombogenic Heparin Coating in 2023
Figure 20. Antithrombogenic Heparin Coating Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 21. Global Antithrombogenic Heparin Coating Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Antithrombogenic Heparin Coating Sales Market Share by Country (2019-2030)
Figure 23. North America Antithrombogenic Heparin Coating Revenue Market Share by Country (2019-2030)
Figure 24. United States Antithrombogenic Heparin Coating Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Antithrombogenic Heparin Coating Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Antithrombogenic Heparin Coating Sales Market Share by Country (2019-2030)
Figure 27. Europe Antithrombogenic Heparin Coating Revenue Market Share by Country (2019-2030)
Figure 28. Germany Antithrombogenic Heparin Coating Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Antithrombogenic Heparin Coating Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Antithrombogenic Heparin Coating Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Antithrombogenic Heparin Coating Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Antithrombogenic Heparin Coating Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Antithrombogenic Heparin Coating Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Antithrombogenic Heparin Coating Revenue Market Share by Region (2019-2030)
Figure 35. China Antithrombogenic Heparin Coating Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Antithrombogenic Heparin Coating Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Antithrombogenic Heparin Coating Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Antithrombogenic Heparin Coating Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Antithrombogenic Heparin Coating Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. China Taiwan Antithrombogenic Heparin Coating Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Southeast Asia Antithrombogenic Heparin Coating Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Latin America Antithrombogenic Heparin Coating Sales Market Share by Country (2019-2030)
Figure 43. Mexico Antithrombogenic Heparin Coating Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Brazil Antithrombogenic Heparin Coating Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Argentina Antithrombogenic Heparin Coating Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Colombia Antithrombogenic Heparin Coating Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Middle East and Africa Antithrombogenic Heparin Coating Sales Market Share by Country (2019-2030)
Figure 48. Middle East and Africa Antithrombogenic Heparin Coating Revenue Market Share by Country (2019-2030)
Figure 49. Turkey Antithrombogenic Heparin Coating Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia Antithrombogenic Heparin Coating Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. UAE Antithrombogenic Heparin Coating Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Global Sales Market Share of Antithrombogenic Heparin Coating by Type (2019-2030)
Figure 53. Global Revenue Market Share of Antithrombogenic Heparin Coating by Type (2019-2030)
Figure 54. Global Antithrombogenic Heparin Coating Price (US$/Kg) by Type (2019-2030)
Figure 55. Global Sales Market Share of Antithrombogenic Heparin Coating by Application (2019-2030)
Figure 56. Global Revenue Market Share of Antithrombogenic Heparin Coating by Application (2019-2030)
Figure 57. Global Antithrombogenic Heparin Coating Price (US$/Kg) by Application (2019-2030)
Figure 58. Antithrombogenic Heparin Coating Value Chain
Figure 59. Antithrombogenic Heparin Coating Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What is the annual compound growth rate of the global Antithrombogenic Heparin Coating market size from 2024 to 2030?
The annual compound growth rate of the global Antithrombogenic Heparin Coating market is 9.2% 2024 to 2030.
Which companies rank high in the global Antithrombogenic Heparin Coating market?
What was the global market size of Antithrombogenic Heparin Coating in 2030?
What was the global market size of Antithrombogenic Heparin Coating in 2024?
Which region is expected to have the highest market share?
Related Reports
Global Antithrombogenic Heparin Coating Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Antithrombogenic Heparin Coating market is projected to grow from US$ 167 million in 2025 to US$ 306 million by 2032, at a CAGR of 9.2% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-24
Pages: 150
USD 4900.00
(Single User License)
Global Antithrombogenic Heparin Coating Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Antithrombogenic Heparin Coating market size was US$ 167 million in 2025 and is forecast to reach a readjusted size of US$ 306 million by 2032 with a CAGR of 9.2% during the forecast period 2026-2032.
Published Date: 2026-03-24
Pages: 80
USD 4250.00
(Single User License)
Antithrombogenic Heparin Coating- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Antithrombogenic Heparin Coating was estimated to be worth US$ 167 million in 2025 and is projected to reach US$ 306 million, growing at a CAGR of 9.2% from 2026 to 2032.
Published Date: 2026-01-19
Pages: 107
USD 3950.00
(Single User License)
Global Antithrombogenic Heparin Coating Market Research Report 2026
The global Antithrombogenic Heparin Coating market was valued at US$ 167 million in 2025 and is anticipated to reach US$ 306 million by 2032, at a CAGR of 9.2% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 114
USD 2900.00
(Single User License)
Global Antithrombogenic Heparin Coating Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Antithrombogenic Heparin Coating market size was US$ 154 million in 2024 and is forecast to a readjusted size of US$ 283 million by 2031 with a CAGR of 9.2% during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 79
USD 4250.00
(Single User License)
Global Antithrombogenic Heparin Coating Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Antithrombogenic Heparin Coating market is projected to grow from US$ 154 million in 2024 to US$ 283 million by 2031, at a CAGR of 9.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-07-31
Pages: 148
USD 4900.00
(Single User License)
Antithrombogenic Heparin Coating - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Antithrombogenic Heparin Coating was estimated to be worth US$ 154 million in 2024 and is forecast to a readjusted size of US$ 283 million by 2031 with a CAGR of 9.2% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 96
USD 3950.00
(Single User License)
Global Antithrombogenic Heparin Coating Market Research Report 2025
The global market for Antithrombogenic Heparin Coating was valued at US$ 154 million in the year 2024 and is projected to reach a revised size of US$ 283 million by 2031, growing at a CAGR of 9.2% during the forecast period.
Published Date: 2025-03-10
Pages: 87
USD 2900.00
(Single User License)
Global and United States Antithrombogenic Heparin Coating Market Report & Forecast 2024-2030
The global Antithrombogenic Heparin Coating revenue was US$ 142 million in 2023 and is forecast to a readjusted size of US$ 261 million by 2030 with a CAGR of 9.2% during the review period (2024-2030).
Published Date: 2024-12-15
Pages: 119
USD 4350.00
(Single User License)
Global Antithrombogenic Heparin Coating Market Insights, Forecast to 2030
Valued at US$ 154 million in 2024, the global Antithrombogenic Heparin Coating market is forecast to reach US$ 261 million by 2030, at a CAGR of 9.2% during the forecast period.
Published Date: 2024-12-15
Pages: 135
USD 4900.00
(Single User License)
Global Antithrombogenic Heparin Coating Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Antithrombogenic Heparin Coating market is projected to grow from US$ 167 million in 2025 to US$ 306 million by 2032, at a CAGR of 9.2% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-24
Pages: 150
USD 4900.00 (Single User License)Global Antithrombogenic Heparin Coating Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Antithrombogenic Heparin Coating market size was US$ 167 million in 2025 and is forecast to reach a readjusted size of US$ 306 million by 2032 with a CAGR of 9.2% during the forecast period 2026-2032.
Published: 2026-03-24
Pages: 80
USD 4250.00 (Single User License)Antithrombogenic Heparin Coating- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Antithrombogenic Heparin Coating was estimated to be worth US$ 167 million in 2025 and is projected to reach US$ 306 million, growing at a CAGR of 9.2% from 2026 to 2032.
Published: 2026-01-19
Pages: 107
USD 3950.00 (Single User License)Global Antithrombogenic Heparin Coating Market Research Report 2026
The global Antithrombogenic Heparin Coating market was valued at US$ 167 million in 2025 and is anticipated to reach US$ 306 million by 2032, at a CAGR of 9.2% from 2026 to 2032.
Published: 2026-01-08
Pages: 114
USD 2900.00 (Single User License)Global Antithrombogenic Heparin Coating Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Antithrombogenic Heparin Coating market size was US$ 154 million in 2024 and is forecast to a readjusted size of US$ 283 million by 2031 with a CAGR of 9.2% during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 79
USD 4250.00 (Single User License)Global Antithrombogenic Heparin Coating Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Antithrombogenic Heparin Coating market is projected to grow from US$ 154 million in 2024 to US$ 283 million by 2031, at a CAGR of 9.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-07-31
Pages: 148
USD 4900.00 (Single User License)Antithrombogenic Heparin Coating - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Antithrombogenic Heparin Coating was estimated to be worth US$ 154 million in 2024 and is forecast to a readjusted size of US$ 283 million by 2031 with a CAGR of 9.2% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 96
USD 3950.00 (Single User License)Global Antithrombogenic Heparin Coating Market Research Report 2025
The global market for Antithrombogenic Heparin Coating was valued at US$ 154 million in the year 2024 and is projected to reach a revised size of US$ 283 million by 2031, growing at a CAGR of 9.2% during the forecast period.
Published: 2025-03-10
Pages: 87
USD 2900.00 (Single User License)Global and United States Antithrombogenic Heparin Coating Market Report & Forecast 2024-2030
The global Antithrombogenic Heparin Coating revenue was US$ 142 million in 2023 and is forecast to a readjusted size of US$ 261 million by 2030 with a CAGR of 9.2% during the review period (2024-2030).
Published: 2024-12-15
Pages: 119
USD 4350.00 (Single User License)Global Antithrombogenic Heparin Coating Market Insights, Forecast to 2030
Valued at US$ 154 million in 2024, the global Antithrombogenic Heparin Coating market is forecast to reach US$ 261 million by 2030, at a CAGR of 9.2% during the forecast period.
Published: 2024-12-15
Pages: 135
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 2900.00
USD 4350.00
USD 5800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now